Abstract:Background: Fragile X syndrome (FXS) is caused by the absence of the mRNA-binding protein Fragile X mental retardation protein (FMRP), encoded by the Fmr1 gene. Overactive signaling by group 1 metabotropic glutamate receptor (Grp1 mGluR) could contribute to slowed synaptic development and other symptoms of FXS. Our previous study has identified that facilitation of synaptic long-term potentiation (LTP) by D1 receptor is impaired in Fmr1 knockout (KO) mice. However, the contribution of Grp1 mGluR to the facilitation of synaptic plasticity by D1 receptor stimulation in the prefrontal cortex has been less extensively studied.Results: Here we demonstrated that DL-AP3, a Grp1 mGluR antagonist, rescued LTP facilitation by D1 receptor agonist SKF81297 in Fmr1KO mice. Grp1 mGluR inhibition restored the GluR1-subtype AMPA receptors surface insertion by D1 activation in the cultured Fmr1KO neurons. Simultaneous treatment of Grp1 mGluR antagonist with D1 agonist recovered the D1 receptor signaling by reversing the subcellular redistribution of G protein-coupled receptor kinase 2 (GRK2) in the Fmr1KO neurons. Treatment of SKF81297 alone failed to increase the phosphorylation of NR2B-containing N-methyl D-aspartate receptors (NMDARs) at Tyr-1472 (p-NR2B-Tyr1472) in the cultures from KO mice. However, simultaneous treatment of DL-AP3 could rescue the level of p-NR2B-Tyr1472 by SKF81297 in the cultures from KO mice. Furthermore, behavioral tests indicated that simultaneous treatment of Grp1 mGluR antagonist with D1 agonist inhibited hyperactivity and improved the learning ability in the Fmr1KO mice.Conclusion: The findings demonstrate that mGluR1 inhibition is a useful strategy to recover D1 receptor signaling in the Fmr1KO mice, and combination of Grp1 mGluR antagonist and D1 agonist is a potential drug therapy for the FXS.

MiR-219 Represses Expression of Dfmr1 in Drosophila Melanogaster.

MiR-315 is Required for Neural Development and Represses the Expression of Dfmr1 in Drosophila Melanogaster

FMRP cooperates with miRISC components to repress translation and regulate neurite morphogenesis in Drosophila

Fragile X mental retardation protein modulates the fate of germline stem cells in Drosophila.

FMRP Acts As a Key Messenger for Dopamine Modulation in the Forebrain

The Conserved Microrna Mir-210 Regulates Lipid Metabolism and Photoreceptor Maintenance in the Drosophila Retina.

Drosophila FMRP controls miR-276-mediated regulation of nejire mRNA for space-filling dendrite development

Drosophila Homolog of FMRP Maintains Genome Integrity by Interacting with Piwi

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

MicroRNA-130b Targets Fmr1 and Regulates Embryonic Neural Progenitor Cell Proliferation and Differentiation

Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132

FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain.

Circadian Rhythm-Dependent Alterations of Gene Expression in Drosophila Brain Lacking Fragile X Mental Retardation Protein.

Identification of Differentially Expressed Micrornas and Their Target Genes in the Hippocampal Tissues of Fmr1 Knockout Mice.

The Microrna Pathway and Fragile X Mental Retardation Protein

Computational Identification and Experimental Validation of MicroRNAs Binding to the Fragile X Syndrome Gene Fmr1

Expression of Transposable Elements in the Brain of the Drosophila melanogaster Model for Fragile X Syndrome

The FMRP–MOV10 complex: a translational regulatory switch modulated by G-Quadruplexes

Group I Mglur Antagonist Rescues the Deficit of D1-induced LTP in a Mouse Model of Fragile X Syndrome

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation Via Distinct Mechanisms

miR-124 controls Drosophila behavior and is required for neural development